Together, these three mechanisms create a uniquely comprehensive metabolic research tool unlike any single or dual agonist
(As compared to GLP1-RA use, in observational new user cohort study from Denmark.) Just published in @DiabetologiaJnl #epitwitter #SGLT2i Full paper: link.springer.com/article/10.100 Thank you to @kidney_boy, Joel Topf, for inspiring us to look at this research question and to @aishaikh, @edgarvlermamd, @ChristosArgyrop, and @asupadh who provided their input in the original thread!#AskRenal Is there data looking at how SGLT2i affects urinary stone profile
Additionally, Mounjaro slows gastric emptying, which moderates the rate at which glucose enters the bloodstream after meals, and it acts on appetite centres in the brain to promote satiety and reduce food intake
This action helps regulate blood sugar levels, promotes insulin secretion, reduces glucagon release, and slows gastric emptying to increase feelings of fullness
No, GLP-1 patches cannot replace GLP-1 injections